SDC1 and Miyoshi myopathy: In addition, the authors have shown that these CAR-T cells can be derived from MM patients and are directed against autologous CD138+ MM cells and putative MM cancer stem cells, ultimately exhibiting significant anti-cancer activity in a xenograft mouse model of MM.